Potential therapeutic applications of aspirin and other cyclo-oxygenase inhibitors

Br J Clin Pharmacol. 1980 Oct;10 Suppl 2(Suppl 2):261S-278S. doi: 10.1111/j.1365-2125.1980.tb01809.x.

Abstract

1 The ubiquitous actions of the cyclo-oxygenase inhibitors are described. 2 These include the inhibitory effect on prostaglandin synthesis and the direct effect of aspirin on lymphocytes and their ability to produce lymphokines. 3 Aspirin reduces some types of platelet aggregation possibly involving inhibition of the precursors of thromboxane A2 and prostacyclin. 4 The therapeutic implications in relation to transient ischaemic attacks, coronary artery disease and reno-allograft rejection are discussed. 5 The beneficial and adverse effects on the gastro-intestinal tract are described. 6 The effects of aspirin-like drugs on the genito-urinary tract are described with particular reference to their adverse effects on labour and their therapeutic effect on dysmenorrhoea.

Publication types

  • Review

MeSH terms

  • Animals
  • Aspirin / therapeutic use*
  • Blood Platelets / drug effects
  • Cardiovascular Diseases / drug therapy
  • Cyclooxygenase Inhibitors*
  • Digestive System / drug effects
  • Hemostasis / drug effects
  • Humans
  • Kidney / physiology
  • Neoplasms / physiopathology
  • Osteolysis / drug effects
  • Prostaglandins / physiology
  • Pulmonary Circulation / drug effects
  • Skin / drug effects
  • Thrombosis / prevention & control
  • Urogenital System / drug effects

Substances

  • Cyclooxygenase Inhibitors
  • Prostaglandins
  • Aspirin